| Ytd | -10.99% | |
| 1y | 48.62% |
| Open | 1.60 | Prev Close | 1.58 | Low | 1.58 | High | 1.66 | Mkt Cap | 75.67M |
| Vol | 163.90K | Avg Vol | 342.92K | EPS | -0.10 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 03-12 | 50-d Avg | 1.47 | 200-d Avg | 1.60 | 1yr Est | 0.00 |
The patent covers the multi-dimensional biological representation layer organized around MindWalk’s
AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. (“MindWalk”) (NASDAQ: HYFT), a
HYFT® technology computationally identified and prioritized a pan-serotype dengue target before immu